risedronic acid has been researched along with Neurodegenerative Diseases in 1 studies
Risedronic Acid: A pyridine and diphosphonic acid derivative that acts as a CALCIUM CHANNEL BLOCKER and inhibits BONE RESORPTION.
Neurodegenerative Diseases: Hereditary and sporadic conditions which are characterized by progressive nervous system dysfunction. These disorders are often associated with atrophy of the affected central or peripheral nervous system structures.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| De Schutter, JW | 1 |
| Park, J | 1 |
| Leung, CY | 1 |
| Gormley, P | 1 |
| Lin, YS | 1 |
| Hu, Z | 1 |
| Berghuis, AM | 1 |
| Poirier, J | 1 |
| Tsantrizos, YS | 1 |
1 other study available for risedronic acid and Neurodegenerative Diseases
| Article | Year |
|---|---|
Multistage screening reveals chameleon ligands of the human farnesyl pyrophosphate synthase: implications to drug discovery for neurodegenerative diseases.
Topics: Allosteric Site; Alzheimer Disease; Catalytic Domain; Crystallography, X-Ray; Diphosphonates; Drug E | 2014 |